Stem, Inc. (NYSE:STEM – Get Free Report) has received a consensus rating of “Hold” from the seven research firms that are covering the stock, Marketbeat.com reports. UBS Group increased their price objective on Stem from $8.60 to $16.00 and gave the stock a “neutral” rating in a research note on Friday, August 22nd. Barclays set a $13.00 target price on Stem and gave the stock an “equal weight” rating in a report on Monday, August 11th. Cerity Partners LLC purchased a new stake in shares of Stem in the 1st quarter worth approximately $29,000. Hedge funds and other institutional investors own 61.63% of the company’s stock.